Search
YaoSu Technology has successfully concluded a fresh round of strategic financing, led by XtalPi. The influx of funds will propel the acceleration of the "3D-Wet-AI" closed-loop technology system and the commercialization trajectory of its international collaborations. YaoSu Technology's flagship platform, EPIC™, seamlessly integrates microfluidic chips, organoid modeling, and AI algorithms, primarily focusing on predicting drug toxicity. Amidst the evolving policies of the FDA in the United States, organoid technology is poised for growth, and YaoSu Technology is actively involved in shaping the relevant standards. The fusion of AI and organ-on-a-chip technology is revolutionizing the approach to new drug R&D, unveiling vast market potential and markedly enhancing R&D efficiency.
-
C114 Communication Network -
Communication Home
